Howard Badel

Howard Badel has extensive experience in sales, particularly in the pharmaceutical and healthcare sectors. Currently serving as a sales representative for Bayer in the Cardio-Renal line since November 2024, Howard previously held various roles at notable companies including Novo Nordisk, where responsibilities included specialized sales in diabetes GLP1 and insulin in the Atlantic Coast region. Howard's background also includes key account management roles at Bristol-Myers Squibb and Laboratorios Bussie S.A, emphasizing the administration of high-cost programs and major accounts. With a solid educational foundation that includes a degree in Economics from Universidad del Atlántico and a specialization in Marketing from Universidad Autónoma del Caribe, Howard is furthering expertise in pharmacoeconomics at Universidad de Antioquia.